
CAS 85933-19-3
:Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
7 produits concernés.
Carbidopa Related Compound A (3-O-Methylcarbidopa)
CAS :Aromatic organic derivatives of hydrazine or of hydroxylamineFormule :C11H16N2O4Couleur et forme :Yellow Tan PowderMasse moléculaire :240.11101rac-Carbidopa EP Impurity C (Carbidopa USP Related Compound A)
CAS :Formule :C11H16N2O4Masse moléculaire :240.26rac-Carbidopa EP Impurity C Trifluoroacetate (Carbidopa USP Related Compound A Trifluoroacetate)
CAS :Formule :C11H16N2O4·C2HF3O2Couleur et forme :White To Off-White SolidMasse moléculaire :240.26 114.02rac-Carbidopa EP Impurity C (Carbidopa USP Related Compound A)
CAS :Produit contrôléFormule :C11H16N2O4Couleur et forme :NeatMasse moléculaire :240.263-O-Methyl Carbidopa
CAS :<p>Applications 3-O-Methylcarbidopa is an impurity of Carbidopa (C175915) with potential use as therapeutic agents to treat hypertension and Parkinson's disease.<br>References Gelber, L. et al.: J. Chrom., 257, 317 (1983); Kallwass, H. et al.: Bioorg. Med. Chem., 2, 557 (1994);<br></p>Formule :C11H16N2O4Couleur et forme :NeatMasse moléculaire :240.263-O-Methyl carbidopa
CAS :Produit contrôlé<p>3-O-Methyl carbidopa is a metabolite of L-3,4-dihydroxyphenylalanine that is used as a drug in the treatment of Parkinson's disease. 3-O-Methyl carbidopa is a racemic mixture of two stereoisomers that have different chemical properties. The (+) form is more active and has been shown to be more potent than the (-) form. Analysis of this compound by magnetic resonance spectroscopy (NMR) at different magnetic fields showed that it has six distinct resonances: three from the protonated molecule and three from the deprotonated molecule. The proton nmr spectrum showed peaks at 2.02 ppm (D1), 2.81 ppm (D2), 3.84 ppm (D3), 4.07 ppm (D4), 4.28 ppm (D5), and 4.53 ppm (D6). These peaks correspond to resonances for protons</p>Formule :C11H16N2O4Degré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :240.26 g/mol






